Citadel Advisors - CHELSEA THERAPEUTICS INTL LT ownership

CHELSEA THERAPEUTICS INTL LT's ticker is and the CUSIP is 163428955. A total of 2 filers reported holding CHELSEA THERAPEUTICS INTL LT in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CHELSEA THERAPEUTICS INTL LT
ValueSharesWeighting
Q1 2014$557,000
+430.5%
100,900
+323.9%
0.00%
Q4 2013$105,000
+32.9%
23,800
-9.2%
0.00%
Q3 2013$79,000
+229.2%
26,200
+154.4%
0.00%
Q2 2013$24,00010,3000.00%
Other shareholders
CHELSEA THERAPEUTICS INTL LT shareholders Q1 2014
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 186,800$1,031,0000.02%
Citadel Advisors 100,900$557,0000.00%
View complete list of CHELSEA THERAPEUTICS INTL LT shareholders